BILAL MIAN: Open Payments
NPI 1700825999 · SOMERVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,015 in 60 payments from 17 companies in 2025. Trend: 2023 $1,084 · 2024 $1,088 · 2025 $1,015
Food & beverage: $1,015
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $258 |
| Novartis Pharmaceuticals Corporation | 9 | $169 |
| PFIZER INC. | 5 | $81 |
| Neurelis, Inc. | 4 | $69 |
| UCB, Inc. | 4 | $68 |
| MDD US Operations, LLC | 3 | $56 |
| ARGENX US, INC. | 3 | $51 |
| Eisai Inc. | 3 | $49 |
| Axsome Therapeutics, Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $37 |
Products named: KESIMPTA, UBRELVY, NURTEC ODT, VALTOCO, Briviact, QULIPTA, VYALEV, VYVGART HYTRULO.
Industry payments across NJ — which companies pay providers there.
